(Q46756852)

24 December 2017

title

The pharmaco-economics of peri-operative statin therapy (English)

1 reference

24 December 2017

1 reference

3

P Foëx

1 reference

24 December 2017

B M Biccard

1

1 reference

24 December 2017

J W Sear

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

24 December 2017

published in

Anaesthesia

1 reference

24 December 2017

volume

60

1 reference

24 December 2017

issue

11

1 reference

24 December 2017

page(s)

1059-1063

1 reference

24 December 2017

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Withdrawal of statins increases event rates in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Early statin initiation and outcomes in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Statins and their role in vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Long-term prognosis after peri-operative cardiac complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

Early Withdrawal of Statin Therapy in Patients With Non–ST-Segment Elevation Myocardial Infarction National Registry of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2044.2005.04371.X

10.1111/J.1365-2044.2005.04371.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16229688

1 reference

24 December 2017